๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kunming
Clinical trial register · China

Clinical Trials in Kunming, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Kunming 18
Narrow the registerReset
Recruitment status
Phase
Site location
Kunming18
All 1 locations
Target enrolment
to

Trials with a site in Kunming

18 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer
NCT07800507NMIBC
Yunnan Cancer Hospital
Phase 1/2
30
Kunming
2026-08-08
Active, closed
Performance of Diffusion-weighted Imaging-based Virtual MR Elastography (vMRE) for Diagnosing Breast Cancer
NCT07608068Breast Cancer, Breast - Female
Yunnan Cancer Hospital
Not applicable
238
Kunming
2025-10-01
Recruiting
The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer
NCT07608081Breast Cancer
Yunnan Cancer Hospital
Not applicable
1,000
Kunming
2025-10-01
Active, closed
Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer
NCT07565818Gastric Cancer
Yunnan Cancer Hospital
Not applicable
260
Kunming
2025-08-04
Active, closed
Study on the Prediction of Regional Lymph Node Metastasis in Colorectal Cancer by Spectral CT Combined With MSI
NCT07565831Colo-rectal Cancer
Yunnan Cancer Hospital
Not applicable
260
Kunming
2025-08-04
Not yet open
EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers
NCT07018505Sentinel Lymph Node, Breast Cancers, Metastases, Margin Assessment
Yunnan Cancer Hospital
Observational
40
Kunming
2025-06-15
Not yet open
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373Colorectal Cancer
Yunnan Cancer Hospital
Not applicable
150
Kunming
2025-06-01
Not yet open
The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
NCT06977399Liver Cancer
Yunnan Cancer Hospital
Not applicable
150
Kunming
2025-06-01
Not yet open
The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
NCT06977386Gastric Cancer
Yunnan Cancer Hospital
Not applicable
150
Kunming
2025-06-01
Recruiting
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563Breast Cancer Metastatic, Sentinel Lymph Node, Sentinel Lymph Node Biopsy (SLNB), Metastasis
Yunnan Cancer Hospital
Observational
60
Kunming
2025-02-01
Recruiting
Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
NCT06972771Bladder Cancer (BC)
Yunnan Cancer Hospital
Observational
40
Kunming
2025-01-17
Recruiting
Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer
NCT07794813Oral Squamous Cell Carcinoma (OSCC), Diagnosis
Yunnan Cancer Hospital
Observational
40
Kunming
2024-12-03
Recruiting
DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
NCT06755866Esophageal Cancer
Yunnan Cancer Hospital
Not applicable
135
Kunming
2024-11-26
Recruiting
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
NCT06742021Lung Cancer
Yunnan Cancer Hospital
Not applicable
195
Kunming
2024-11-11
Recruiting
Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status
NCT06713161Breast Cancer, Sentinel Lymph Node, Metastases, Margin Assessment
Yunnan Cancer Hospital
Observational
40
Kunming
2024-09-01
Recruiting
Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
NCT06735118Non-Alcoholic Fatty Liver Disease
Yunnan Cancer Hospital
Not applicable
120
Kunming
2023-12-25
Recruiting
Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
NCT06735105Gastric Cancer
Yunnan Cancer Hospital
Not applicable
129
Kunming
2023-12-23
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/kunming

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Kunming that also match the filters currently applied.

How many clinical trials are recruiting in Kunming?

10 of the 18 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kunming), 18 studies
PhaseStudiesRecruitingShare
Not applicable11561.1%
Observational6533.3%
Phase 1/2105.6%

Most active sponsors

Lead sponsors with the most studies (Kunming)
Lead sponsorStudiesRecruiting
Yunnan Cancer Hospital1810
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.